Chair of the Board, TransCelerate BioPharma; Head, Global Development Janssen Research & Development, LLC
Kathryn (Kate) Owen is Head, Global Development at Janssen Research & Development, LLC. Kate previously was the head of global clinical development operations at Bristol Myers Squibb. In this role, she led and managed all operations related to the conduct of Bristol Myers Squibb clinical trials – clinical pharmacology studies as well as Phase I through IV.
While Kate’s responsibilities focus on global operational execution, she has a passion for assuring the opportunity & the education of clinical trials is afforded broadly.
Prior to BMS, she spent more than eight years in a range of positions of increasing responsibility at Covance after having started her career in the UK in oncology-focused biotech. Kate received her undergraduate degree from Royal Holloway, University of London in Biology.